{
  "id": 1431,
  "text": "0 4 )$ .There was a suggestion of trend in the relative effect of chemoradiotherapy by tumour stage $( \\mathrm { p } ~ = ~ 0 .0 1 7 )$ ), with the benefit of chemoradiotherapy decreasing with increasing stage (stage IB-IIA: $1 0 \\%$ , stage IIB: $7 \\% ,$ stage III-IVA: $3 \\%$ ).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 0 4 )$ .There was a suggestion of trend in the relative effect of chemoradiotherapy by tumour stage $( \\mathrm { p } ~ = ~ 0 .0 1 7 )$ ), with the benefit of chemoradiotherapy decreasing with increasing stage (stage IB-IIA: $1 0 \\%$ , stage IIB: $7 \\% ,$ stage III-IVA: $3 \\%$ ).\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "对于宫颈癌患者，不同肿瘤分期对化疗联合放疗的相对疗效确实存在趋势变化。随着肿瘤分期的增加，化疗联合放疗的相对疗效有所下降。具体而言，早期分期（IB-IIA阶段）的疗效最高，约为10%；而在中期分期（IIB阶段），疗效下降至约7%；到了晚期分期（III-IVA阶段），疗效进一步降低至约3%。这种趋势提示，在早期分期的宫颈癌患者中，化疗联合放疗可能具有更显著的优势，而在更晚的肿瘤分期中，其益处则较为有限。",
  "query": "根据您的要求提供问题：  \n\n对于不同肿瘤分期，化疗联合放疗的相对疗效是否存在趋势变化？如果存在，疗效随分期的变化情况如何？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 根据您的要求提供问题：  \n\n对于不同肿瘤分期，化疗联合放疗的相对疗效是否存在趋势变化？如果存在，疗效随分期的变化情况如何？\n\n<reference text>: 0 4 )$ .There was a suggestion of trend in the relative effect of chemoradiotherapy by tumour stage $( \\mathrm { p } ~ = ~ 0 .0 1 7 )$ ), with the benefit of chemoradiotherapy decreasing with increasing stage (stage IB-IIA: $1 0 \\%$ , stage IIB: $7 \\% ,$ stage III-IVA: $3 \\%$ ).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "对于宫颈癌患者，不同肿瘤分期对化疗联合放疗的相对疗效确实存在趋势变化。随着肿瘤分期的增加，化疗联合放疗的相对疗效有所下降。具体而言，早期分期（IB-IIA阶段）的疗效最高，约为10%；而在中期分期（IIB阶段），疗效下降至约7%；到了晚期分期（III-IVA阶段），疗效进一步降低至约3%。这种趋势提示，在早期分期的宫颈癌患者中，化疗联合放疗可能具有更显著的优势，而在更晚的肿瘤分期中，其益处则较为有限。"
}